CHUV
Les activités du CHUV
MENU
Service
d'immunologie et allergie
Accueil > Research > Vaccine and Immunotherapy Center > About us - A propos de nous

Contact


Division of Immunology and Allergy
Vaccine and Immunotherapy Center
1011 Lausanne, Switzerland


Tel.: +41 21 314 1160 / +41 21 314 1163
Fax: +41 21 314 1161
E-mail

Monday to Friday: 8 am - 6 pm

Clinical research unit
 

IAL/VIC Laboratory research unit


The Vaccine and Immunotherapy Center (VIC) was created in 2001 by Prof. Giuseppe Pantaleo, MD, head of the Division of Immunology and Allergy at the Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Switzerland.
 

The VIC is a clinical and laboratory research platform specialized in vaccinology, clinical research, immune-monitoring and basic immunology. It has gained over the years experience and expertise in the design, implementation and realization of clinical trials, particularly in the fields of HIV, malaria, tuberculosis, hepatitis C, and other infectious diseases. The VIC has been designed to conduct mainly phase I and II trials, with the main goals being the assessment of the safety, as well as the evaluation of the immune responses of experimental vaccines.
 

The VIC clinical unit has developed a Manual of Operating Procedures (MOP), stating all the procedures and stages of a clinical trial, from the submission to the regulatory authorities (Ethics Committee, Swissmedic), to the follow-up of study participants. The VIC’s staff works accordingly to strict ethical regulations and internationally recognized Good Clinical Practices (GCP) and Human Subject Protection (HSP) policies. These rigorous procedures guarantee both precision and quality in clinical trial management. In addition to its track record of efficiency in volunteer recruitment, VIC also has a high rate of volunteer retention throughout the trials.
 

The IAL/VIC laboratory unit is certified ISO/IEC 17025 by the Swiss Accreditation Service. This certification is in compliance with Good Laboratory Practice (GLP) guidelines regarding the handling, processing, storage and traceability of clinical trial samples, assay standardization, data management and documentation required for submissions to regulatory agencies. Most assays developed to date in our laboratory have been validated in the context of clinical trials. As such, the IAL/VIC laboratory is a Standard Operating Procedure (SOP)-driven, quality controlled, immune-monitoring platform.
 

The Laboratory of AIDS Immunopathogenesis was created in 1997 by Pr. Giuseppe Pantaleo, MD, head of the Division of Immunology and Allergy at the Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Switzerland.